MedPath

Health in Smart Rurality: Impact on Coordination of Care of Telemonitoring and Data Centralization of Frailty Patients

Conditions
Chronic Obstructive Pulmonary Disease
Heart Failure
Interventions
Other: Data collection
Registration Number
NCT04866550
Lead Sponsor
Université de Reims Champagne-Ardenne
Brief Summary

Chronic diseases are frequent (around 10% of the total population and 30% after 60 years) and accelerate age-related functional decline. Concerning cross-border patients, use of health services can be delayed given the distances, the lack of rapid road access and the limited availability of public transport and the complex organization of coordinated care.

One of the ways to reduce acute exacerbations and preserve the quality of life of patients is to detect warning signs early. One of the ways to do this is to use new communication technologies.

Detailed Description

The aim of the study is to assess feasibility of using a connected tablet to assess clinical parameters with an alert system in frailty patients aged over 60, living at home, with heart failure and / or chronic obstructive pulmonary disease, potentially requiring care cross-border (France and Belgium).

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Patients aged over 60
  • Patients living at home
  • Patients with heart failure and / or chronic obstructive pulmonary disease,
  • Patients potentially requiring care cross-border (France and Belgium).
  • Patients agreeing to participate to the study
Exclusion Criteria
  • Patients who do not speak French
  • Patients with severe cognitive impairment

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Connected tabletData collectionPatients aged over 60, living at home, with heart failure and / or chronic obstructive pulmonary disease, potentially requiring care cross-border (France and Belgium).
Primary Outcome Measures
NameTimeMethod
Alert according to the connected tablet12 months

significant change in temperature (egal or more 38°), weight (variation of more than 5%), heart rate (less than 50 beats per minute or greater than 100), systolic blood pressure (less than 85 mmHg or greater than 160 mmHg) and / or oxygen saturation (variation of more than 4%)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Université de Reims Champagne-Ardenne

🇫🇷

Reims, France

© Copyright 2025. All Rights Reserved by MedPath